Atlas Trials

A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients

Clinical trial NCT03258320 · RECRUITING

Trial details

NCT number
NCT03258320
Sponsor
Shanghai Jiao Tong University School of Medicine
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Prostate Cancer Patients
Start date
2015-01-01
Primary completion
2026-12-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.